2013 – Invokana approved by FDA

Announcement Date: March 29, 2013

March 29, 2013 – Invokana (canagliflozin) approved by the U.S. Food & Drug Administration (FDA) as an adjunct to diet and exercise to help improve glycemic control in adults with type 2 diabetes.